Anti-Mullerian Hormone Deficiency, Post Partum Hemorrhage
Conditions
Brief summary
Anti-Mullerian hormone (AMH) is a marker for ovarian reserve. There are many studies about AMH changes in ovarian surgery, but little is known for other surgeries. We seek to investigate the hormone variations before and after uterine artey ligation for postpartum hemorrage (PPH)
Detailed description
All patients belong to the same group. The blood samples will be collected at the time of surgery and 3 months after surgery from the patients who need uterine artery ligation for PPH. The blood samples will be centrifuged within 2 hours after being obtained and assessed on the same day. AMH concentrations will be measured with an enzymatically amplified two-sided immunoassay
Interventions
OTHERanti- mullerian hormone
All patients belong to the same group. The blood samples will be collected at the time of surgery and 3 months after surgery from the patients who need uterine artery ligation for PPH. The blood samples will be centrifuged within 2 hours after being obtained and assessed on the same day. AMH concentrations will be measured with an enzymatically amplified two-sided immunoassay
Sponsors
Kanuni Sultan Suleyman Training and Research Hospital
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes
Inclusion criteria
* age 18- 40 years * no systemic or endocrine diseases * patients who had uterine artery ligation due to PPH
Exclusion criteria
* Pregnancy with IVF or oosit donation * Patients with endocrinopathy, diseases which require radiotherapy and chemotherapy etc. * Patients with BMI \>40
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 1- Anti-Mullerian Hormone levels variation | 3 months | Anti-Mullerian Hormone levels before and 3 months after surgery |
Countries
Turkey (Türkiye)
Outcome results
None listed